Diabetes Sentry hopes to get funding for blood glucose monitor

07/28/2010 | MedCityNews.com

Diabetes Sentry Products hopes to secure as much as $1.5 million in financing to further develop a watchlike device that can warn diabetic patients when their blood-sugar levels are too low. However, some experts say the device, which uses a sensor to track a patient's skin temperature and perspiration, might be outpaced by new glucose monitors and insulin pumps.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX